BANK OF AMERICA CORP /DE/
BankPosition in CATX — Perspective Therapeutics, Inc.
CIK 70858
CHARLOTTE, NC
Position in CATX
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$1,008,822
-$158,604 QoQ
Shares Held
241,924
-43.0% QoQ
Ownership
0.212%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $9,233,942,756 across 89 Medical Devices names. CATX ranks #56 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
26,015,003 | $2,254,200,007 | |
| 2 | ABT |
Abbott Laboratories
|
19,279,608 | $1,979,437,350 | |
| 3 | BSX |
Boston Scientific Corp
|
22,756,646 | $1,427,979,535 | |
| 4 | SYK |
Stryker Corp
|
4,113,757 | $1,351,739,409 | |
| 5 | EW |
Edwards Lifesciences Corp
|
3,883,419 | $310,984,191 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
4,132,740 | $294,168,429 | |
| 7 | STE |
STERIS plc
|
922,164 | $203,918,121 | |
| 8 | DXCM |
Dexcom Inc
|
2,933,726 | $184,237,991 |
All Filings in CATX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,008,822 | 241,924 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,167,426 | 424,519 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,695,372 | 785,823 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $1,126,599 | 327,500 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $642,840 | 301,803 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $155,597 | 48,777 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,327,491 | 174,344 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $674,519 | 67,655 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||